T. Tanaka

Genetic alterations and expression of the protein phosphatase 1 genes in human cancers.

A. Okamoto, J. Yokota, T. Kohno, 2001, International journal of oncology.

IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta.

A. Okamoto, T. Nikaido, B. Kalionis, 2006, Placenta.

Phase II study of gefitinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) gene mutations detected by PNA-LNA PCR clamp.

K. Hagiwara, H. Miyazawa, A. Sutani, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp

K. Hagiwara, M. Kanazawa, H. Miyazawa, 2006, British Journal of Cancer.

Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B

Huqun, H. Miyazawa, K. Hagiwara, 2008, Oncogene.

Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice.

B. Huppertz, C. Ra, S. Nunomura, 2012, Placenta.